Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Other financing activities (2021 - 2025)

HCW Biologics (HCWB) has disclosed Other financing activities for 4 consecutive years, with $63500.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other financing activities changed N/A year-over-year to $63500.0, compared with a TTM value of $1.5 million through Sep 2025, changed N/A, and an annual FY2024 reading of $638045.0, changed N/A over the prior year.
  • Other financing activities was $63500.0 for Q3 2025 at HCW Biologics, down from $802602.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $824312.0 in Q2 2021 and bottomed at -$924312.0 in Q3 2021.
  • Average Other financing activities over 4 years is $190776.8, with a median of $100000.0 recorded in 2021.
  • Peak annual rise in Other financing activities hit 115.67% in 2022, while the deepest fall reached 115.67% in 2022.
  • Year by year, Other financing activities stood at -$924312.0 in 2021, then skyrocketed by 104.94% to $45677.0 in 2022, then soared by 1296.86% to $638045.0 in 2024, then crashed by 90.05% to $63500.0 in 2025.
  • Business Quant data shows Other financing activities for HCWB at $63500.0 in Q3 2025, $802602.0 in Q2 2025, and $22297.0 in Q1 2025.